In a development that is being hailed as a significant milestone in the field of in vitro fertilization, Auxogyn Inc. (Menlo Park, CA) has announced that its Eeva System test has received clearance from the FDA. The test is the first ...
Tags: Certification, Service, Health, Medicine, FDA
Metso Corporation’s Extraordinary General Meeting (EGM) held in Helsinki, October 1, 2013, approved the Board of Directors’ proposed plan for partial demerger and decided to demerge Metso into two companies. Metso’s Pulp, ...
Auxogyn has announced the availability of early embryo viability assessment (Eeva) test at Sims IVF clinic located in Ireland. Eeva test has been designed to improve the vitro fertilization (IVF) outcomes by assessing the viability of the ...
Auxogyn has obtained CE mark approval for its non-invasive early embryo viability assessment (Eeva) test, designed to improve in vitro fertilization (IVF) outcomes. By using intelligent computer vision software, Eeva test measures ...
Merck Serono has entered into a collaboration agreement to provide strategic, scientific and medical support in the development and commercialization of Auxogyn's proprietary Early Embryo Viability Assessment (Eeva) test. The Eeva test, ...
Tags: Eeva test, non-invasive computerized test, embryo selection
Santen Europe has selected Sparta Systems' TrackWise Enterprise Quality Management Solution (EQMS) to centralize the European management of its regulatory affairs processes. The regulatory affairs processes include product registration ...
Tags: Santen, Sparta Systems TrackWise, EQMS, ophthalmic pharmaceuticals
Merck Serono, a division of Merck, and Auxogyn have partnered to develop Early Embryo Viability Assessment (Eeva) test. Pursuant to the deal, Merck Serono will provide strategic, scientific and medical support for the development of ...
Tags: Early Embryo Viability Assessment test, eeva test, clinical development